James Sapirstein First Wave Bio Pharma, Inc. (FWBI) insider trading activity

James Sapirstein is Chairman and CEO of First Wave BioPharma, Inc.. Currently has a direct ownership of 37,105 shares of FWBI, which is worth approximately $45,639. The most recent transaction as insider was on Apr 01, 2024, when has been sold 174 shares (Common Stock) at a price of $4.23 per share, resulting in proceeds of $736. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 37.1K

0.47% 3M change

6.09% 12M change

Total Value Held $45,639

JAMES SAPIRSTEIN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 01 2024	SELL Open market or private sale	$736 $4.23 p/Share	174 Reduced 0.47%	37,105 Common Stock
Mar 15 2024	SELL Open market or private sale	$9,359 $4.96 p/Share	1,887 Reduced 4.82%	37,279 Common Stock
Jan 12 2024	SELL Open market or private sale	$697 $4.2 p/Share	166 Reduced 0.42%	39,166 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	20,000 Added 33.71%	39,332 Common Stock
Dec 29 2023	BUY Grant, award, or other acquisition	-	17,660 Added 47.74%	19,332 Common Stock
Oct 04 2023	SELL Open market or private sale	$801 $0.29 p/Share	2,764 Reduced 7.64%	33,397 Common Stock
Jul 03 2023	SELL Open market or private sale	$5,157 $1.54 p/Share	3,349 Reduced 8.48%	36,161 Common Stock

Apr 03 2023	SELL Open market or private sale	$8,367 $2.5 p/Share	3,347 Reduced 7.81%	39,510 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	300,000 Added 50.0%	300,000 Common Stock

Also insider at

ENOB

Enochian Biosciences Inc Healthcare

Director

MRZM

MARIZYME INC Healthcare

Interim CEO

BWV

Blue Water Vaccines Inc. Healthcare

Director